We commend the board for taking a hard look at CYGS
and hope board members apply the same rigorous standards to the remaining 55 community-based anti-delinquency organizations.
officials did not return a call seeking comment.
Studies now in progress at several universities, independent laboratories, and biotech companies continue to demonstrate the ability of the CYGS vector to synthesize single strands of sequence specific DNA in the nucleus of selected cell lines for Antisense purposes.
The CYGS vectors solve this problem by actually synthesizing the designated ODNs in the nucleus of the targeted cells.
The Simian Immuno Virus (SIV) animal studies are intended to demonstrate the ability of the CYGS
vector to synthesize pharmacologically significant titers of sequence specific, antisense competent ODN's in an animal model.
Elliston's responsibilities at CYGS
overlap three critical areas", according to Executive Vice President, Dell Gibson.
has developed an effective delivery mechanism for anti-sense oligodeoxyribonucleotides (ODN's).
has exclusive rights to the ssDNA vector technology developed by Dr.
All proposals will be submitted to the CYGS
Scientific Advisory Board for evaluation and approval.
Further details and references to specific patents are available on the CYGS
is currently conducting experiments to demonstrate that their ssDNA expression vector delivers antisense molecules into the cells of living animals, including humans, in sufficient quantities to be pharmacologically significant.
The kits will be provided to researchers for experimental purposes only and are governed by Materials Transfer Agreements between CYGS
and the research facilities.